4 ms·
Novartis revenue from Cosentyx is 3 billion for the first 6 months of 2024, and up 20% YoY. There is absolutely some shenanigans going on, but most of that goe
by s1artibartfast 2y ago
Novartis revenue from Cosentyx is 3 billion for the first 6 months of 2024, and up 20% YoY.
There is absolutely some shenanigans going on, but most of that goes on with the Pharmacy benefits manager.
- jasonjayr 2y agoRight, so, My insurer is United, the Pharmacy is OptumRX, the PBM is OptumRX, and the discount program is from Novartis. All these parties (ultimately 2?) are doing something to their balance sheets.
- ceejayoz 2y agoYes. For example: https://www.propublica.org/article/when-buying-prescription-drugs-some-pay-more-with-insurance-than-without-it https://www.propublica.org/article/when-buying-prescription-... https://www.propublica.org/article/take-the-generic-drug-patients-are-told-unless-insurers-say-no https://www.propublica.org/article/take-the-generic-drug-pat... https://www.nytimes.com/2024/04/07/us/health-insurance-medical-bills-takeaways.html https://www.nytimes.com/2024/04/07/us/health-insurance-medic...
- s1artibartfast 2y agoRight. PBMs and insurance make large profits, and that is additive to that of the manufacturers. I wonder what the total cost to patients of the drug is.
- gusgus01 2y agoI'm not sure if it was the point, but both United Healthcare Insurance and OptumRx are both owned by United Health Group. Also I think it's about 1 in 10 doctors in the US work for them in one form or another. They've been in the news a bunch this year.